Medical economics

Start talking about mRNA vaccine access now, say experts

While researchers are still in the early stages of development for new mRNA vaccines, global health leaders focused on the world's most neglected infectious diseases say that conversations about access should begin now.

Vaccination

WTO mulling intellectual property waivers for vaccines

Ambassadors from World Trade Organization countries on Wednesday resumed discussions on trade rules protecting the technological know-how behind COVID-19 vaccines amid growing pressure on rich nations to relax them—as a ...

page 3 from 4